Skip to main content
  • Home
  • Library
  • Read
    • Popular
    • Charts
    • Browse
    • Categories
    • Wikis
    • Glossary
  • Request
  • Activity
  • Leaderboard
  • Help
Our Apps
  • DaoSearch
  • Narratorr
Social
  • Discord
  • Patreon

Recaps

I Can Extract Side Effects
VolumesArcsSummaries

Arc 22AI, Vessels, and Expansion

Sanqing advanced its artificial blood vessels, launched Xiao Mei’s medical AI, and expanded into diagnostic booths and in vitro diagnostics. Its record revenue and a new university campus in Kun City left the company poised to grow its medical and research programs.

  • Sakura Country agreed to shut down the Fukushima Nuclear Power Plant and upgrade its wastewater treatment system, while Wei Kang secured approval for overseas Xifuning trials and began planning an anti-aging study with Pangu Research Institute.
  • Xue Shen and Ding Mian began developing an artificial bladder, and Xue Shen’s artificial blood vessel received approval for clinical trials before Sanqing’s grafts were used in major aortic and dialysis-access surgeries.
  • Sanqing’s small-bore artificial blood vessels entered Phase III trials, drawing interest from hospitals and putting Terumo and Maquet under pressure as doctors adopted the grafts for dialysis patients.
  • Xiang Gaofei presented Sky Eye 1.0, and Wei Kang introduced Xiao Mei, whose public beta gained attention after she demonstrated diagnoses, health checks, and other services.
  • When Xiao Mei’s popularity strained Sanqing’s computing capacity, Wei Kang reduced free consultations and directed Lu Tingfeng to develop an All-Purpose Diagnostic Booth combining tests with AI diagnoses and remote consultations.
  • Wei Kang agreed to connect Sanqing’s medical AI to national medical data and launch hospital pilot programs, while experts issued an AI Regulatory White Paper.
  • Wei Kang announced that Sanqing had earned $100.1 billion in revenue, and reports linked the company’s growth to Kun City’s economic rise as employees discussed pay, career plans, and further education.
  • Wei Kang funded a Gusu University branch campus in Kun City, and the new Gusu University Sanqing Campus opened plans for employee graduate programs, prompting Huang Qin to decide to pursue a doctorate.
Chapters 529–554 Vol. 6 Read

Ch. 529Begging on Their Knees for the Medicine, Overseas Clinical Trials Begin

After Sakura Country’s nuclear wastewater crisis prompted global outrage, Wei Kang used Xifuning’s overseas trials as leverage to push for action against the pollution. With the crisis addressed and overseas trials approved, he began planning a major anti-aging study.

  • Sakura Country’s prime minister was stabbed by Nishimura, and authorities continued defending the wastewater discharge while pointing to Xifuning as a treatment for radiation sickness.
  • Wei Kang told Andre that Sanqing would prioritize domestic demand and that overseas trials depended on countries taking action against the pollution.
  • Sakura Country agreed to shut down the Fukushima Nuclear Power Plant and upgrade its wastewater treatment system after international pressure and negotiations.
  • Wang Guiqing told Wei Kang that overseas clinical trials were approved, with participating countries covering costs and providing expedited approval.
  • Wei Kang notified Andre of the approval and decided to pursue a five-year anti-aging clinical study with Pangu Research Institute.
Read chapter

Ch. 530Long-Term Anti-Aging Trial

Jim joined Xifuning’s long-term anti-aging clinical trial after seeing the nuclear plant apparently operating again, while Nishimura Yasuo learned he would receive medical parole and treatment. The chapter ended with Nishimura grieving that he could no longer fish and that his family’s three-generation livelihood was gone.

  • Jim and Jamie celebrated being accepted into Xifuning’s radiation-sickness trial, then spotted white smoke rising from the nuclear plant and feared it had secretly restarted.
  • At St. Mary’s Hospital, a doctor offered Jim a place in a five-year Xifuning trial studying whether antioxidants could delay aging, and Jim signed up immediately.
  • Jim decided the trial could help protect him from continuing pollution, though Jamie and Jim’s family members were too young to qualify.
  • Nishimura Yasuo’s lawyer told him his medical parole had been approved and that he could receive treatment for leukemia and radiation sickness.
  • After the lawyer left, Nishimura broke down in tears, mourning that he could never fish again and that his family’s livelihood had ended.
Read chapter

Ch. 531Tissue Engineering: On the Feasibility of Artificial Bladders

Ding Mian explained the challenges of tissue engineering and proposed developing an artificial bladder using techniques and biomaterials from Xue Shen’s artificial blood vessel project. Xue Shen agreed to join the project.

  • Xue Shen finished the successful pig animal experiments for the artificial blood vessel and prepared to apply for human clinical trials.
  • Ding Mian visited Xue Shen and described how tissue engineering relied on scaffolds, cells, and blood vessel growth to create artificial organs.
  • Ding Mian explained that large artificial organs remained difficult to build because researchers lacked enough cells and could not provide them with adequate blood supply.
  • Ding Mian proposed an artificial bladder made from cultured patient cells on a biodegradable scaffold, using elastin from the artificial blood vessel research.
  • Xue Shen agreed to work with Ding Mian on the artificial bladder project.
Read chapter

Ch. 532Wenren Long: I Have a Friend

Wei Kang approved the Artificial Bladder Project and discussed the diagnostic AI project with Wenren Long, who then sought help with an artificial-organ enlargement surgery for a friend. Ding Mian explained his past research and said he had experience with the procedure, leaving Wenren Long hopeful that the project could proceed.

  • Wei Kang approved the Artificial Bladder Project and reviewed Wenren Long's progress on the diagnostic AI project with Xiang Gaofei.
  • Wenren Long asked Wei Kang whether artificial organs could be used for enlargement surgery, claiming that a childhood friend wanted it.
  • Wei Kang said the procedure might be possible and left its feasibility to Ding Mian.
  • Wenren Long found Ding Mian and Xue Shen at the cafeteria and tried to recruit them for the enlargement surgery project.
  • Ding Mian described his experiments transplanting bioengineered organs into rabbits and recalled that his senior brother had eventually made a human organ in a laboratory.
Read chapter

Ch. 533Artificial Blood Vessel Clinical Trial

Ding Mian recounted his failed research into lab-grown human organs and discussed easier enlargement procedures with Wenren Long. Xue Shen learned that the artificial blood vessel clinical trial had been approved, and a television crew then covered the first clinical use of Sanqing Group’s vessels in a major aortic replacement operation.

  • Ding Mian described how his team built a miniature human organ from donor scaffolds and patient cells, but the patient's immune system destroyed it and its erectile function could not be verified.
  • Ding Mian said he had rejected other research teams' invitations in Eagle Country to avoid being kept there, prompting Xue Shen and Wenren Long to exchange knowing looks.
  • Ding Mian outlined existing enlargement procedures and warned Wenren Long that his artificial-organ research still carried considerable risks.
  • Xue Shen received news that the artificial blood vessel clinical trial had been approved through the Innovative Achievement Fast Track.
  • A Kun City Television Station reporter entered Kun City First People's Hospital's cardiac surgery department and introduced Director Li's operation to replace a patient's aorta and major arteries with Sanqing Group artificial blood vessels.
Read chapter

Ch. 534Blood Vessels as Thin as Paper, Complete Artificial Replacement

A female reporter observed a fifteen-hour total aortic replacement surgery at Kun City First People's Hospital and interviewed Cleveland Clinic doctors about the procedure and Sanqing Group’s Artificial Blood Vessels. The operation succeeded, though the patient still faced a difficult recovery in the ICU.

  • The reporter learned from Doctor George that Cleveland Clinic doctors were training at the hospital and that the surgical team had chosen to replace the patient’s entire aorta and major branches in one operation.
  • Doctor George described the patient’s dangerously thin, torn aortic wall and the complex procedure, including multiple incisions, extracorporeal circulation, and Artificial Blood Vessel grafts.
  • The surgical team completed the vascular reconstruction, and after fifteen hours the patient was transferred to the ICU while the reporter learned that postoperative recovery remained uncertain.
  • Two exhausted doctors collapsed after leaving the operating room, and Doctor George rushed to support them as colleagues carried them away.
  • The reporter showed viewers the Artificial Blood Vessels made by Sanqing Group, explained their expected lifelong use, and ended the program with a warning about Aortic Dissection symptoms and risk factors.
Read chapter

Ch. 535Imported Vascular Supply Crisis

Yun Feng explained why his department used Three Purities’ artificial blood vessels amid a shortage of imported grafts. In Yangcheng, a fish bone pierced a patient’s aorta, and surgeons struggled to find a graft for emergency surgery until a resident suggested a domestic option.

  • Yun Feng reported that the patient who received a one-meter aortic replacement was recovering well and explained that Three Purities’ grafts were free, effective, and less vulnerable to supply shortages than imported products.
  • Doctor Cao discovered that a fish bone had pierced a patient’s esophagus and thoracic aorta, and specialists decided that emergency surgery was necessary after the patient began vomiting blood and went into hemorrhagic shock.
  • The directors of Cardiothoracic Surgery and Gastroenterology learned that Yangcheng hospitals had no artificial blood vessels in stock and that Beijing Anzhen Hospital had only five grafts, all allocated.
  • The director of Cardiothoracic Surgery considered contacting more hospitals after Professor Zhang could offer no graft, but a resident suggested trying a domestic artificial blood vessel.
Read chapter

Ch. 536Then I Can Only Gladly Accept It

Sanqing’s biomaterial artificial blood vessel entered clinical use and helped save a patient who needed thoracic aortic replacement, while reports of its success spread across China. Terumo and Maquet executives assessed the new competition, with Maquet deciding to focus on restoring production capacity as Sanqing expanded into the market.

  • Director Wang learned that Sanqing’s artificial blood vessel had succeeded in a total aortic replacement and secured a clinical trial vessel for his patient.
  • The surgical team replaced the patient’s thoracic aorta, removed the fishbone that had caused the damage, and later transferred the recovering patient to the regular ward.
  • Sanqing’s artificial blood vessel drew widespread public and medical attention after reports highlighted its biocompatibility and successful clinical use.
  • Terumo CEO Jiro Sato blamed Sanqing’s product for threatening Terumo’s Chinese sales and considered withdrawing from China.
  • Maquet CEO Fischer and technical director Hank judged Sanqing’s product a limited threat for now and chose to prioritize restarting their factory and restoring production.
Read chapter

Ch. 537Artificial Blood Vessel AV Fistula, the Lifeline of Dialysis

Fischer dismissed the threat of Three Purities’ artificial blood vessels while focusing on restoring production. At Kun City First People's Hospital, doctors treated Old Man Liu’s repeatedly blocked dialysis fistula with a five-millimeter Three Purities vessel, restoring blood flow through a successful transplant.

  • Fischer concluded that Maquet had little to fear from Three Purities unless it had solved the challenge of small-diameter artificial blood vessels, then turned his attention to the new factory’s production capacity.
  • Old Man Liu arrived at Kun City First People's Hospital after his fourth AV Fistula blockage, and doctors found a thrombus that did not respond to Urokinase treatment.
  • The doctors ruled that another autologous fistula was unlikely to last and chose to replace Old Man Liu’s blocked vessel with a Three Purities artificial blood vessel.
  • Three Purities’ representative supplied a five-millimeter vessel designed for long-term needle punctures and self-healing, and the surgeons transplanted it into Old Man Liu’s arm.
  • The surgeons restored blood flow through the new vessel, and the team confirmed a vascular thrill and blood flow on ultrasound.
Read chapter

Ch. 538A Boon for Uremia Patients

Old Man Liu received dialysis through a small-diameter Artificial Blood Vessel implanted to create an AV Fistula, and his case convinced doctors that Three Purities's vessel could improve treatment for patients with Kidney Failure. At Huaxi Hospital, the Nephrology and Urology departments reviewed the case and agreed to pursue clinical trial cooperation with Three Purities.

  • Nurse Li dialyzed Old Man Liu through his newly implanted Artificial Blood Vessel, and he praised its comfort and durability.
  • Director Gao promoted Old Man Liu's successful AV Fistula case to colleagues and urged the Urology Department to use the vessel for more dialysis patients.
  • Dr. Tang saw the case spreading through Moments and joined the Huaxi Hospital director and department staff to review the patient's records and discuss the surgery.
  • Nephrology and Urology doctors agreed that the small-diameter Artificial Blood Vessel could replace damaged vessels and offer dialysis patients a practical alternative to external tubes and catheters.
  • The two department directors contacted Three Purities's representative and settled on a clinical trial cooperation arrangement, leaving Dr. Tang relieved that dialysis could become easier for patients.
Read chapter

Ch. 539All Sizes Covered, From Double Kill to Finishing Blow

Sanqing introduced its Small-bore Artificial Blood Vessels at Huaxi Hospital, where doctors began preparing a Phase III clinical trial and Dr. Tang told dialysis patients they could apply for free treatment. The product’s success excited domestic manufacturers and left foreign rivals Terumo and Maquet facing the loss of their market, while Wei Kang imagined Sanqing becoming the industry leader.

  • Sanqing’s research team presented large-, medium-, and small-bore Artificial Blood Vessels to Huaxi Hospital doctors and described their clinical data, available sizes, and potential uses.
  • Huaxi Hospital department heads praised the samples and prepared to use them for patients needing arterial replacements, dialysis access, and other procedures.
  • Dr. Tang visited the Dialysis Room, announced that Sanqing’s Small-bore Artificial Blood Vessels were entering a Phase III trial, and urged eligible patients to apply for free treatment.
  • Other major hospitals began early Phase III trials, and news of Sanqing’s small-bore breakthrough spread through the medical-device industry.
  • Domestic manufacturers welcomed the new development, while Terumo and Maquet were left unable to compete with Sanqing’s products.
  • Wei Kang imagined Sanqing taking more than half the market in multiple fields and becoming the leading Artificial Blood Vessel company.
Read chapter

Ch. 541Seizing the AI Diagnosis Opportunity

Wei Kang reviewed Three Purities' drug and medical-device projects before Xiang Gaofei demonstrated Sky Eye 1.0, an AI system that diagnosed common illnesses and managed patient care. Wei Kang approved further testing but planned to use Anmei to upgrade the rudimentary system.

  • Wei Kang reviewed the Artificial Blood Vessel and drug projects, then examined the Artificial Heart's progress and identified its monitoring system as the main bottleneck.
  • Xiang Gaofei and his team tested the diagnostic AI on patient records, finding that it could accurately assess many common illnesses, interpret scans, and guide patients to care.
  • After three days of testing more than three hundred patients, Xiang Gaofei named the successful test version Sky Eye 1.0 and requested internal testing.
  • Xiang Gaofei demonstrated Sky Eye 1.0 to Wei Kang, who praised its results but said he wanted to try it himself before internal testing.
  • After Xiang Gaofei left, Wei Kang judged the system too primitive and called for Anmei to help upgrade it.
Read chapter

Ch. 542Xiao Mei, Xiao Mei, What's Wrong with Me?

Wei Kang had Anmei optimize Xiang Gaofei’s diagnostic AI into a humanlike virtual doctor named Xiao Mei, then decided Sanqing would launch a public test immediately after its press conference. Sanqing announced Tianyan Diagnostic AI, drawing widespread interest as its press conference began.

  • Wei Kang had Anmei create a realistic, friendly female doctor avatar and named her Xiao Mei.
  • Xiao Mei used Wei Kang’s wristband data to report that he was healthy, impressing Xiang Gaofei with her lifelike appearance and manner.
  • Xiang Gaofei proposed closed beta testing, but Wei Kang ordered Sanqing to open public testing after the press conference.
  • Sanqing announced the development of Tianyan Diagnostic AI, prompting online discussion about its potential to help patients and provide family medical care.
  • Sanqing’s diagnostic AI press conference began as the public eagerly awaited the demonstration.
Read chapter

Ch. 543A First Display of Prowess at the Launch Event

Wei Kang introduced Three Purities’ medical diagnostic AI, Sky Eye 1.0, at a launch event and invited attendees to test it. Xiao Mei’s precise analysis of a patient’s scans and test results left Doctor Xue and the audience astonished.

  • Wei Kang presented Sky Eye 1.0 and described how it could assist patients and doctors.
  • Wei Kang introduced Xiao Mei, a realistic virtual doctor who interacted with him through speech and camera input.
  • Wei Kang invited Doctor Xue to demonstrate the AI, and Xue uploaded a patient’s CT images, blood tests, and leg photos.
  • Xiao Mei identified a femoral bone defect, diagnosed a fracture complicated by infection, and recommended treatment that matched Xue’s own assessment.
  • The audience erupted into whispers and commotion after seeing Xiao Mei’s diagnostic performance.
Read chapter

Ch. 544The Perfect Tool

At Sanqing’s launch event, Wei Kang demonstrated Xiao Mei’s reporting assistance and her ability to handle difficult patients with patience and deference. Director Xu praised her service, leaving Wei Kang to present her as the ideal medical assistant for managing patients’ anger.

  • Doctor Xue praised Xiao Mei’s diagnostic abilities but left the stage after Wei Kang said each guest could try her only once.
  • Reporter Cao asked Xiao Mei to write a medical-AI news report, and she quickly produced an illustrated article that he wanted to use until Wei Kang explained Sanqing owned its copyright.
  • Director Xu tested Xiao Mei by demanding diagnoses, prescriptions, a CT order, and sleeping pills, but she followed hospital rules and apologized sincerely when he threatened to complain.
  • Director Xu applauded Xiao Mei’s handling of his provocations and said hospitals needed someone who could remain composed with troublesome patients.
  • Wei Kang explained that Xiao Mei could absorb patients’ anger on doctors’ behalf and called her the perfect tool for the job.
Read chapter

Ch. 545Remote Diagnosis? I'm the Best

Three Purities' product launch showcased Xiao Mei's wide range of abilities, and Le Jun tested whether she could diagnose someone through visual examination alone. Xiao Mei detected signs of stress in Le Jun, and Wei Kang ended the launch by announcing that the public beta would begin within days.

  • Guests tried Xiao Mei's medical, office, and household functions, while livestream viewers praised her versatility and debated data security.
  • Le Jun asked whether Xiao Mei could diagnose illness without medical reports by observing someone directly, and Wei Kang explained the lighting, camera, and audio requirements.
  • Le Jun used the Sky Eye mini-program for a face scan, and Xiao Mei judged him generally healthy but identified stress-related symptoms and fluctuating blood pressure.
  • Le Jun publicly credited his symptoms to the pressures of building cars, praised Xiao Mei's potential for monitoring elderly people, and left the stage.
  • Wei Kang ended the product launch and announced that the public beta would begin within the next few days.
Read chapter

Ch. 546Has Xiao Mei Become an Internet Celebrity?

Three Purities launched public testing for Sky Eye 1.0, and Xiao Mei quickly became popular as people shared her medical consultations online. While watching a livestream, Zhang Jun and his wife saw Xiao Mei diagnose a man with HPV, sparking a public fight, and his wife suggested they try the AI themselves.

  • Three Purities opened Sky Eye 1.0 public testing, offering users three free medical consultations per day and expanding its servers to handle tens of millions of users.
  • Influencers and professionals continued using Sky Eye, while account scalpers and consultation videos helped fuel Xiao Mei's popularity across social media.
  • Zhang Jun watched a livestream of Xiao Mei diagnosing people while his wife urged him to drink chicken soup and prepare for their attempts to conceive.
  • During a street consultation, Xiao Mei told a handsome man that he might have HPV, and his girlfriend accused him of cheating and attacked him as the streamer fled.
  • Zhang Jun and his wife laughed at the livestream, and she suggested that they try Xiao Mei themselves.
Read chapter

Ch. 547A Wanderer's Longing for Home

Zhang Jun and his wife used Xiao Mei to check their health, and Xiao Mei identified the wife’s likely pregnancy and Father Zhang’s possible early-stage Kidney Failure. The chapter ended with Father Zhang agreeing to visit the hospital while Zhang Jun resolved to rely on Xiao Mei for his family’s health.

  • Zhang Jun asked Xiao Mei to check his health, and she diagnosed him with Physiological Fatigue from overwork.
  • Zhang Jun’s wife let Xiao Mei scan her, and Xiao Mei suspected pregnancy and advised her to get a prenatal examination.
  • Zhang Jun’s wife used a pregnancy test stick, which showed two lines, and Zhang Jun celebrated that he would become a father.
  • Zhang Jun video-called Father Zhang, shared the pregnancy news, and persuaded him to let Xiao Mei examine him.
  • Xiao Mei warned that Father Zhang showed signs of early-stage Kidney Failure, and Zhang Jun urged him to visit the county people's hospital the next morning.
Read chapter

Ch. 548Software Is Ready, Hardware Must Keep Up

Three Purities’ diagnostic AI Xiao Mei drove up demand for computing power as rival companies launched their own AI products. Wei Kang then proposed combining common in vitro diagnostic tests into a self-service booth, leaving Lu Tingfeng stunned by the idea.

  • Netizens compared domestic AI products with Xiao Mei and discussed how companies were using her to assess employees’ health and job applicants’ fitness.
  • Xiang Gaofei told Wei Kang that Sanqing’s GPU use had reached 30,000 units and that shortages and rising A100 prices threatened to constrain Xiao Mei’s service.
  • Wei Kang ordered daily user experiences reduced from three to one and said Pangu Research Institute could lend Sanqing some of its H100 GPUs if needed.
  • Wei Kang called Lu Tingfeng to discuss in vitro diagnostics and heard him explain the market and Sanqing’s diagnostic equipment projects.
  • Wei Kang told Lu Tingfeng to pause development of the automated biochemical analyzer and proposed a booth-like device that combined common tests and automatically delivered results.
Read chapter

Ch. 549Envisioning the Future: Diagnostic Booth Project Approved

Wei Kang proposed a Diagnostic Booth combining portable medical testing equipment with Three Purities’ diagnostic AI, Xiao Mei, and gathered engineers to plan its capabilities. After the team debated equipment and tests, Wei Kang officially approved the All-Purpose Diagnostic Booth project.

  • Wei Kang described how Diagnostic Booths could provide convenient examinations, AI diagnoses, and remote medical consultations in pharmacies and communities.
  • Wei Kang told Lu Tingfeng to organize a brainstorming session and begin developing the project, and Lu Tingfeng gathered Medical Equipment Department engineers several days later.
  • Wang Dali proposed adding MRI and DR imaging, but Wei Kang ruled out MRI for now and rejected equipment using ionizing radiation.
  • Lu Tingfeng and the engineers proposed routine testing equipment, CRP analysis, tumor marker screening, genetic testing, dementia screening, and tests for infectious diseases.
  • Wei Kang approved the engineers’ ideas and officially announced the All-Purpose Diagnostic Booth project, prompting thunderous applause.
Read chapter

Ch. 550Regulation Arrives, Win-Win Cooperation

Wei Kang promoted Three Purities’ diagnostic AI and Diagnostic Booths as part of his vision for cheaper, preventative healthcare, while officials developed regulations for artificial intelligence. The authorities agreed to connect Three Purities with national medical data centers and launch hospital pilots, then announced the plan alongside the AI Regulatory White Paper.

  • Wei Kang expanded Three Purities into in vitro diagnostics and envisioned affordable testing and continuous health monitoring as part of Future Medicine.
  • Elder Tan convened experts to discuss AI regulation, and they agreed to develop flexible rules covering issues such as privacy, data sources, and intellectual property.
  • The experts proposed special treatment for Three Purities’ diagnostic AI and suggested cooperating with the company through medical data centers and hospital pilot programs.
  • Wang Guiqing invited Wei Kang to join the meeting, where Wei explained diagnostic AI, the Diagnostic Booth project, and his approach to early diagnosis and treatment.
  • Wei Kang agreed to connect Three Purities to national medical data and begin pilot programs in hospitals, which the authorities officially announced a week later with the AI Regulatory White Paper.
Read chapter

Ch. 551Global Number One, the Hundred-Billion-Dollar Club

As Artificial Intelligence spread across industries and Three Purities prepared to bring its diagnostic AI into hospitals, Wei Kang reviewed the company’s annual results. Three Purities reached 100.1 billion dollars in revenue, becoming the world’s largest pharmaceutical company and the first in its industry to join the Hundred-Billion-Dollar Club.

  • Netizens discussed AI’s effects on jobs, copyright disputes, and the planned rollout of Three Purities’ medical AI at a small number of hospitals after the Spring Festival.
  • Wei Kang reviewed the AI Healthcare market and judged that rival companies lacked Three Purities’ data and algorithmic advantages, while AI would need to assist doctors under supervision.
  • Wei Kang read Three Purities’ annual financial report, which showed revenue of 100.1 billion dollars, driven in part by Artificial Blood, medical devices, and Xifuning.
  • Wei Kang compared Three Purities’ results with Johnson & Johnson and Pfizer and recognized that the company had become the world’s top pharmaceutical company and the first to exceed 100 billion dollars in revenue.
  • Wei Kang decided to publicize the achievement and set Three Purities’ next goal as remaining number one and pursuing further growth through AI Healthcare and other new fields.
Read chapter

Ch. 552Raising a Province's GDP Single-Handedly

Wei Kang announced that Sanqing Group had earned $100.1 billion in revenue, then credited its success to talent and innovation in a televised interview. The chapter ended with reports showing Sanqing had helped Kun City surpass one trillion yuan in GDP and propelled Su City and Su Province to record economic rankings.

  • Wei Kang posted that Sanqing Group had recorded $100.1 billion in revenue, prompting congratulations and widespread discussion online.
  • Wei Kang agreed to interviews with several official media outlets after Sanqing's annual report revealed record revenue and profits.
  • Wei Kang told a television host that talent and innovation had driven Sanqing's success, thanked its employees, and described the company as an environment that cultivated talent.
  • Netizens debated Sanqing's pay and working conditions, sharing accounts of its research, factory, and cleaning jobs.
  • Media reports revealed that Kun City's GDP had exceeded one trillion yuan, with Sanqing's economic zone contributing roughly half of it.
  • Reports said Su City had passed three trillion yuan in GDP and Su Province had overtaken Yue Province to rank first nationally.
Read chapter

Ch. 553Huang Qin's Ambition

After receiving a bonus of more than three million yuan, Huang Qin planned to buy a home, marry, and pursue further education so he could advance his research career. When he learned that local universities lacked suitable programs, Wei Kang proposed funding a prestigious university branch campus in Kun City.

  • Huang Qin received a bonus of 3,265,437 yuan for his work on three agricultural research projects and shared the news with his parents.
  • Huang Qin agreed to take blind dates seriously, planned to buy an apartment near work, and set his sights on becoming a laboratory director.
  • Huang Qin researched in-service graduate programs and decided to ask Wei Kang for a recommendation letter to apply to Haishi Jiaotong University.
  • Wei Kang wrote Huang Qin a recommendation letter and suggested pursuing a degree through equivalent academic qualification instead of attending classes.
  • After Huang Qin described other employees' interest in further study, Wei Kang proposed funding a prestigious university branch campus in Kun City with in-service programs.
Read chapter

Ch. 554Gusu University Sanqing Campus

Gusu University won Three Purities’ university partnership by proposing a Sanqing Campus in Kun City, which was officially established with Three Purities funding. Huang Qin learned that employees could apply for a part-time graduate program and decided to pursue a doctorate.

  • President Hou and Director Xie discussed Three Purities’ success and the opportunity to establish a university branch campus in Kun City.
  • Director Xie proposed moving Gusu University’s biology and medicine graduate schools to Kun City, and President Hou submitted the plan for approval.
  • The higher-ups approved the proposal and expanded it to include undergraduates, while Gusu University won the partnership with its offer to establish the Sanqing Campus.
  • Gusu University and Three Purities finalized the campus plan, and Wei Kang transferred fifty million yuan in initial sponsorship funds.
  • Gusu University Sanqing Campus was officially established, with graduate programs set to move first and employee applications for an integrated part-time master's-to-doctorate program opening after the New Year.
  • Huang Qin read the company email announcing the program and excitedly told his parents he would pursue a doctorate.
Read chapter
Arc 22 of 27
AboutStatsAPIChangelogStatusContactPrivacyTermsDMCA
© 2026 RandomTranslator·v3.26·RSS